Karyopharm schedules investor call on myelofibrosis trial results

June 1, 2026 7:30 AM

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) announced it will host an investor conference call on June 2, 2026 at 2:00 p.m ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found